Direct Meds review
One of the rare programs offering an oral/sublingual route on both molecules with all-inclusive pricing — marked down hard because the numbers are company-stated rather than independently verified, and the company carries an FDA warning letter from September 2025.
Direct Meds — FDA warning letter, September 2025. Addressed to directmeds.com, Inc. dba DirectMeds, and public in FDA’s warning-letter database.
- Semaglutide
- $179/mo
- Tirzepatide
- $224/mo
- Coverage
- Not publicly listed
- Brand-name
- Compounded only
The scorecard
Direct Meds scored on our six published factors. See the methodology.
What we like
- Rare oral/sublingual drops on both molecules — sublingual semaglutide from $179/mo and tirzepatide from $224/mo — plus an injectable path
- All-inclusive pricing with no separate membership fee to layer on top
- Covers both semaglutide and tirzepatide rather than a single molecule
The caveats
- Every option is compounded, not FDA-approved
- Pricing is company-stated (from a press release) and not independently verified — treat the figures as claims, not confirmed rates
- Newer entity (est. 2024) operating across several similar-looking domains, so confirm you're on the right one
- States served are not disclosed, so coverage can't be verified before you sign up
- FDA issued a warning letter to directmeds.com, Inc. dba DirectMeds in September 2025; it is public in FDA's warning-letter database
The verdict
Best for: Needle-averse patients who specifically want a sublingual GLP-1 option and are willing to vet a newer operator themselves. One of the rare programs offering an oral/sublingual route on both molecules with all-inclusive pricing — marked down hard because the numbers are company-stated rather than independently verified, and the company carries an FDA warning letter from September 2025.
Ranked #30 of 539 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. In the ranking it sits between Renlo Health at #29, 85/100 above and Alan Meds at #31, 84/100 below, with the Henry Meds ruling the next one down.
If that ruling leaves you undecided, the 7 programs we rank against Direct Meds are graded on the same six factors and listed in score order.If you would rather start from the top of the field, our full board of 539 providers is the place to start if you are still shortlisting. We have also ruled on it directly: CoreAge Rx vs Direct Meds goes to CoreAge Rx, 94/100 to 82/100.
Compare with other providers
The closest rulings to Direct Meds by Verdict Score — the realistic shortlist if you are weighing this one up.
- #33Live Vital— Cheap semaglutide and nationwide coverage, with a tirzepatide markup and no LegitScript listing.83/100
- #34REMEVi— REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.83/100
- #35Rx.com— Prints "No automatic renewals" on the plan card and names the pharmacy that dispenses — then advertises a price belonging to a different drug on a different term.82/100
- #36Synergy Rx— Will prescribe brand Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited round-the-clock access to its clinical team.79/100
- #37Mochi Health— A recognizable coaching-forward brand undercut by a limited state footprint and no LegitScript listing.81/100
- #38Fella Health— A men's-health-focused program with a steep tirzepatide price, a partial state map and no LegitScript listing.81/100
Pricing, states and verification reflect Direct Meds's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Direct Meds's site. Not medical advice; see our disclosure.